Danske Bank’s Lucid Diagnostics LUCD Stock Holding History

Danske Bank’s Portfolio LUCD Stock Details LUCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1	Hold	1	–	–	﹤0.01%	1142
2026 Q1	$1	Hold	1	–	–	﹤0.01%	1164
2025 Q4	$1	Hold	1	–	–	﹤0.01%	1554
2025 Q3	$1	Hold	1	–	–	﹤0.01%	1479
2025 Q2	$1	Hold	1	–	–	﹤0.01%	1511
2025 Q1	$1	Hold	1	–	–	﹤0.01%	1360
2024 Q4	$1	Hold	1	–	–	﹤0.01%	1397
2024 Q3	$1	Buy	+1	New	+$1	﹤0.01%	1586

Other funds holding LUCD

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Danske Bank's LUCD Position: Q2 2026 in Review

Danske Bank held its Lucid Diagnostics (LUCD) position steady in Q2 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #1142.

Danske Bank first reported a position in LUCD in Q3 2024 and has held it in 8 quarters since. 116 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

Danske Bank held 1 share of Lucid Diagnostics worth $1 as of Q2 2026.
Danske Bank left its Lucid Diagnostics share count unchanged in Q2 2026.
Lucid Diagnostics made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #1142 holding.
Danske Bank first reported a position in Lucid Diagnostics in Q3 2024 and has held it in 8 quarters since.
116 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.